Loading...
The First Frontier: Digital Biomarkers for Neurodegenerative Disorders
Current measures of neurodegenerative diseases are highly subjective and based on episodic visits. Consequently, drug development decisions rely on sparse, subjective data, which have led to the conduct of large-scale phase 3 trials of drugs that are likely not effective. Such failures are costly, d...
Na minha lista:
| Udgivet i: | Digit Biomark |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7015357/ https://ncbi.nlm.nih.gov/pubmed/32095743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000477383 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|